Start / The Long Run with Luke Timmerman / Ep151 shelley force aldred and nathan trinklein on bispecific antibodies for cancer

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

64 min • 26 december 2023

Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.

Kategorier

Förekommer på

00:00 -00:00